We first evaluated the in vitro effect of ERW on the growth of human breast cancer cell lines (MCF-7 and MDA-MB-453), characterized by different expression of estrogen (ER), progesterone (PR), and ErbB2 receptors, and of tumor suppressor p53 [32–36] (Table 1). Here, TP53 is linked to breast carcinoma.